Latest Releases
Jan 06, 2025
Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager
Read More »Dec 16, 2024
Candid Therapeutics and EpimAb Biotherapeutics Enter Into Research Collaboration to Discover and Develop Novel T-Cell Engagers for Autoimmune Indications
Read More »Dec 16, 2024
Candid Therapeutics and Ab Studio Enter Into Research Collaboration to Discover and Develop Novel T Cell Engagers for Autoimmune Indications
Read More »Dec 16, 2024
Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers
Read More »Oct 16, 2024
Candid Therapeutics Appoints Highly Accomplished Industry Leaders Angie You, Ph.D. and Dan Puckett to it’s Board of Directors
Read More »Sep 09, 2024